117 related articles for article (PubMed ID: 15642420)
1. The prevalence of non-sentinel node metastases in breast cancer patients with sentinel node micrometastases.
Leidenius MH; Vironen JH; Riihelä MS; Krogerus LA; Toivonen TS; von Smitten KA; Heikkilä PS
Eur J Surg Oncol; 2005 Feb; 31(1):13-8. PubMed ID: 15642420
[TBL] [Abstract][Full Text] [Related]
2. A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis.
Houvenaeghel G; Nos C; Giard S; Mignotte H; Esterni B; Jacquemier J; Buttarelli M; Classe JM; Cohen M; Rouanet P; Penault Llorca F; Bonnier P; Marchal F; Garbay JR; Fraisse J; Martel P; Fondrinier E; Tunon de Lara C; Rodier JF
Eur J Surg Oncol; 2009 Jul; 35(7):690-5. PubMed ID: 19046847
[TBL] [Abstract][Full Text] [Related]
3. Prediction of non-sentinel lymph node status in breast cancer with a micrometastatic sentinel node.
Schrenk P; Konstantiniuk P; Wölfl S; Bogner S; Haid A; Nemes C; Jagoutz-Herzlinger M; Redtenbacher S
Br J Surg; 2005 Jun; 92(6):707-13. PubMed ID: 15810047
[TBL] [Abstract][Full Text] [Related]
4. [Critical study of our initial experience of 993 sentinel node biopsies for breast surgery].
Martel P; Capdet J; Méry E; Zerdoud S; Ferron G; Rafii A; Roché H; Querleu D
Bull Cancer; 2008; 95(7):763-72. PubMed ID: 18755653
[TBL] [Abstract][Full Text] [Related]
5. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
Tvedskov TF
Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
[TBL] [Abstract][Full Text] [Related]
6. The role of axillary lymph node dissection in breast cancer patients with sentinel lymph node micrometastases.
Gipponi M; Canavese G; Lionetto R; Catturich A; Vecchio C; Sapino A; Friedman D; Cafiero F
Eur J Surg Oncol; 2006 Mar; 32(2):143-7. PubMed ID: 16300921
[TBL] [Abstract][Full Text] [Related]
7. A decision aid for predicting non-sentinel node involvement in women with breast cancer and at least one positive sentinel node.
Farshid G; Pradhan M; Kollias J; Gill PG
Breast; 2004 Dec; 13(6):494-501. PubMed ID: 15563857
[TBL] [Abstract][Full Text] [Related]
8. Evaluating TIMP-1, Ki67, and HER2 as markers for non-sentinel node metastases in breast cancer patients with micrometastases to the sentinel node.
Tvedskov TF; Bartels A; Jensen MB; Paaschburg B; Kroman N; Balslev E; Brünner N
APMIS; 2011 Dec; 119(12):844-52. PubMed ID: 22085360
[TBL] [Abstract][Full Text] [Related]
9. Sentinel node biopsy is not sensible in breast cancer patients with large primary tumours.
Leidenius MH; Krogerus LA; Toivonen TS; von Smitten KA
Eur J Surg Oncol; 2005 May; 31(4):364-8. PubMed ID: 15837040
[TBL] [Abstract][Full Text] [Related]
10. An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement.
Barranger E; Coutant C; Flahault A; Delpech Y; Darai E; Uzan S
Breast Cancer Res Treat; 2005 May; 91(2):113-9. PubMed ID: 15868438
[TBL] [Abstract][Full Text] [Related]
11. The risk of non-sentinel metastases in primary breast cancer.
Bauerfeind IG; Kahlert S; Himsl I; Sorokina Y; Ruehl IM; Lebeau A; Linke R; Untch M; Friese K
Anticancer Res; 2007; 27(4A):1929-32. PubMed ID: 17649798
[TBL] [Abstract][Full Text] [Related]
12. Determination of sentinel lymph node (SLN) status in primary breast cancer by prospective use of immunohistochemistry increases the rate of micrometastases and isolated tumour cells: analysis of 174 patients after SLN biopsy.
Rydén L; Chebil G; Sjöström L; Pawlowski R; Jönsson PE
Eur J Surg Oncol; 2007 Feb; 33(1):33-8. PubMed ID: 17174513
[TBL] [Abstract][Full Text] [Related]
13. The prevalence of and risk factors for four or more metastatic axillary lymph nodes in breast cancer patients undergoing sentinel node biopsy.
Leidenius M; Vaalavirta L; Heikkilä P; von Smitten K; Salmenkivi K
J Surg Oncol; 2008 Jul; 98(1):21-6. PubMed ID: 18484087
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for non-sentinel lymph node metastases in patients with breast cancer. The outcome of a multi-institutional study.
Bolster MJ; Peer PG; Bult P; Thunnissen FB; Schapers RF; Meijer JW; Strobbe LJ; van Berlo CL; Klinkenbijl JH; Beex LV; Wobbes T; Tjan-Heijnen VC
Ann Surg Oncol; 2007 Jan; 14(1):181-9. PubMed ID: 17028772
[TBL] [Abstract][Full Text] [Related]
15. Tumour-positive sentinel node findings in patients with ductal carcinoma in situ.
Leidenius M; Salmenkivi K; von Smitten K; Heikkilä P
J Surg Oncol; 2006 Oct; 94(5):380-4. PubMed ID: 16967467
[TBL] [Abstract][Full Text] [Related]
16. S-classification of sentinel lymph node predicts axillary nonsentinel lymph node status in patients with breast cancer.
Fink AM; Lass H; Hartleb H; Jurecka W; Salzer H; Steiner A
Ann Surg Oncol; 2008 Mar; 15(3):848-53. PubMed ID: 18043975
[TBL] [Abstract][Full Text] [Related]
17. Axillary recurrence rate after tumour negative and micrometastatic positive sentinel node procedures in breast cancer patients, a population based multicenter study.
Bulte CS; van der Heiden-van der Loo M; Hennipman A
Eur J Surg Oncol; 2009 Jan; 35(1):25-31. PubMed ID: 18640809
[TBL] [Abstract][Full Text] [Related]
18. [Sentinel node biopsy without systematic axillary dissection: study about 1000 procedures].
Giard S; Chauvet MP; Houpeau JL; Baranzelli MC; Carpentier P; Fournier C; Belkacemi Y; Bonneterre J
Gynecol Obstet Fertil; 2005 Apr; 33(4):213-9. PubMed ID: 15894205
[TBL] [Abstract][Full Text] [Related]
19. [Sentinel lymph node biopsy in breast cancer].
Schlichting E; Harr ME; Sauer T; Babovic A; Kåresen R
Tidsskr Nor Laegeforen; 2006 Aug; 126(16):2098-100. PubMed ID: 16932777
[TBL] [Abstract][Full Text] [Related]
20. [Low invasion in sentinel lymph node according to the European Working Group In Breast Screening Pathology (EWGBSP) recommendations and non sentinel invasion risk in breast cancer].
Gauthier T; Fermeaux V; Mollard J; Aubard Y
Gynecol Obstet Fertil; 2009 Jun; 37(6):481-7. PubMed ID: 19457697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
